ALEF Accreditations: DHHS

United States Department of Health & Human Services (DHHS)


The United States Department of Health and Human Services (DHHS), often called simply the Health Department, is a cabinet-level department of the U. S. federal government. Its goal is to protect the health of all Americans, as well as to provide essential human services, especially for those who are least able to help themselves.

HHS administers 115 programs across 11 operating divisions and its annual budget is over $1 trillion. Several HHS agencies are components of the USPHS or Public Health Service (PHS), including the Substance Abuse and Mental Health Services Administration (SAMHSA). HHS also oversees the Health Insurance Portability and Accountability Act (HIPAA). It is primarily through SAMHSA and HIPAA that ALEF is involved with the HHS.

For instance, one of SAMHSA’s main priorities is expand access to opioid addiction treatment and recovery support services. That includes increasing access to Food and Drug Administration (FDA) approved Medication-Assisted Treatment (MAT). While HIPAA, on the other hand, ensures medical professionals respect and carry-out basic human health rights throughout the United States.

In 2017, HHS launched a 5-Point Opioid Strategy designed to empower local communities on the frontlines of the epidemic. And in 2018, the department awarded over $1 billion to implement the plan.

The U.S. Department of Health and Human Services (HHS) is a trillion dollar federal agency that oversees the health and welfare of all Americans. ALEF is proud to help HHS uphold its very noble mission.

Suffer no more.
Call us right now.

HHS’ 5-Point Strategy To Combat the Opioid Crisis


  • Better Prevention, Treatment and Recovery
  • Better Data
  • Better Pain Management
  • Better Availability of Overdose Preventing Drugs
  • Better Research


Here are some of the Strategy’s essential details:

BETTER ADDICTION PREVENTION, TREATMENT, AND RECOVERY SERVICES


As the heading implies, the point of this strategy is to improve access to prevention, treatment, and recovery support services all across America. That is, to prevent the health, social, and economic consequences associated with opioid abuse, misuse and addiction, as well as to enable individuals to achieve long-term recovery.

The Treatment component includes enabling individuals, families, and caregivers to find, access, and navigate evidence-based treatments for opioid use disorder (OUD), as well as identifying and disseminating best practices related to Medication-Assisted Treatment (MAT). The Recovery point includes providing culturally and linguistically appropriate education and support to individuals, families, and caregivers so they may better understand the importance of recovery, as well as helping them find and access a wide range of evidence-based services.

BETTER DATA


The Better Data point of the HHS Strategy includes strengthening public health data reporting and collection, improving the timeliness and specificity of data, and helping to create a real-time public health response as the opioid epidemic evolves. It also includes collecting and disseminating actionable data, deploying local and regional resources, and assessing the impacts of federal, state, and local efforts.

BETTER PAIN MANAGEMENT


Better Pain Management is especially crucial in light of the role prescription pain medication has played in creating the opioid epidemic. This HHS Strategy Point includes advancing the practice of pain management, enabling access to the kind of high-quality, evidence-based pain care that reduces the burden of pain for individuals, families, and society, as well as simultaneously reducing the inappropriate use of opioids. The Better Pain Management component also includes providing prescribers with actionable information such as the Centers for Disease Control and Prevention (CDC) Guideline for Prescribing Opioids for Chronic Pain, so that they’re current on the appropriate use of opioids and other pain treatment modalities. This helps to ensure that patients’ pain management needs are met, yet also significantly reduces the risk of opioid addiction.

BETTER TARGETING OF OVERDOSE REVERSING DRUGS

This point of the Strategy has already made significant headway across America. And it’s saved an untold number of lives to boot. As implied, the component targets the availability and distribution of overdose-reversing medications to people likely to experience or respond to an overdose. That is to say, it’s geared toward getting drugs such as naloxone to addicts and their loved ones, as well as to first responders. And while the effort currently focuses on high-risk populations, its implementation is country- wide.

BETTER RESEARCH

Research has always been a crucial component of addiction, as well as recovery. This point not only supports the kind of cutting-edge research that advances our understanding of pain, overdose and addiction, but also the sort of research that leads to the development of new treatments. Among other components, it’s also designed to identify effective public health interventions that will help reduce opioid-related harms.

ALEF & HHS


ALEF is proud to comply with each and every requirement set fort by the United States Health and Human Services Administration (HHS), especially those that fall under the auspices of the Substance Abuse and Mental Health Services Administration (SAMHSA). We’re also proudly in compliance with all aspects of the Health Insurance Portability and Accountability Act (HIPAA). Like HHS, our goal is to protect the health of the country, as well as to provide essential human services to its citizens. And while we may focus on those affected by the opioid crisis; we’re also well aware that this epidemic impacts everyone.

Join the Recovery Community
Find Out How Now.


ALEF is proud to be a part of the DHHS's 5-Point Opioid Strategy, because we too are committed to empowering local communities across America.

DHHS - Opioid Use Disorder Treatment Centers